home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

142 rows where docket_id = "FDA-2023-N-2177" and posted_year = 2023 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Supporting & Related Material 128
  • Other 13
  • Proposed Rule 1

posted_year 1

  • 2023 · 142 ✖

agency_id 1

  • FDA 142
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-2177-7194 FDA None FDA-2023-N-2177 Request for Extension from World Marrow Donor Association Other Request for Extension 2023-11-27T05:00:00Z 2023 11 2024-11-04T05:00:00Z   2024-11-04T20:43:12Z   0 0 09000064862b6bb6
FDA-2023-N-2177-1256 FDA None FDA-2023-N-2177 Request for Extension from American Society for Clinical Pathology Other Request for Extension 2023-11-13T05:00:00Z 2023 11 2023-11-13T05:00:00Z   2023-11-13T16:04:55Z   0 0 0900006486238c7e
FDA-2023-N-2177-1149 FDA None FDA-2023-N-2177 Response to Request for Comment Period Extension Other Response(s) 2023-11-02T04:00:00Z 2023 11 2023-11-02T04:00:00Z   2023-11-02T19:55:26Z   0 0 09000064861d8b7d
FDA-2023-N-2177-1135 FDA None FDA-2023-N-2177 Request for Extension from Academy of Clinical Laboratory Physicians and Scientists et al Other Request for Extension 2023-10-31T04:00:00Z 2023 10 2023-10-31T04:00:00Z   2023-10-31T18:38:25Z   0 0 09000064861a4b16
FDA-2023-N-2177-1130 FDA None FDA-2023-N-2177 Request for Extension from Foundation for the Accreditation of Cellular Therapy Other Request for Extension 2023-10-31T04:00:00Z 2023 10 2023-10-31T04:00:00Z   2023-10-31T18:28:19Z   0 0 090000648618cc65
FDA-2023-N-2177-1129 FDA None FDA-2023-N-2177 Request for Extension from American Hospital Association Other Request for Extension 2023-10-31T04:00:00Z 2023 10 2023-10-31T04:00:00Z   2023-10-31T18:24:43Z   0 0 090000648618c3e9
FDA-2023-N-2177-1115 FDA None FDA-2023-N-2177 Request for Extension from American Clinical Laboratory Association Other Request for Extension 2023-10-30T04:00:00Z 2023 10 2023-10-30T04:00:00Z   2023-10-30T13:28:44Z   0 0 0900006486151c95
FDA-2023-N-2177-1066 FDA None FDA-2023-N-2177 Request for Extension from Coalition for Innovative Laboratory Testing Other Request for Extension 2023-10-26T04:00:00Z 2023 10 2023-10-26T04:00:00Z   2023-10-26T14:09:18Z   0 0 09000064861080d7
FDA-2023-N-2177-1094 FDA None FDA-2023-N-2177 Request for Extension from American Society for Microbiology Other Request for Extension 2023-10-26T04:00:00Z 2023 10 2023-10-26T04:00:00Z   2023-10-26T14:23:31Z   0 0 0900006486123f0c
FDA-2023-N-2177-1096 FDA None FDA-2023-N-2177 Request for Extension from American College of Medical Genetics and Genomics Other Request for Extension 2023-10-26T04:00:00Z 2023 10 2023-10-26T04:00:00Z   2023-10-26T14:25:17Z   0 0 090000648612a070
FDA-2023-N-2177-1098 FDA None FDA-2023-N-2177 Request for Extension from American Red Cross Other Request for Extension 2023-10-26T04:00:00Z 2023 10 2023-10-26T04:00:00Z   2023-10-26T14:25:41Z   0 0 09000064861374ad
FDA-2023-N-2177-0135 FDA None FDA-2023-N-2177 PRIA Reference 45 - Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-06T04:00:00Z 2023 10     2023-10-06T15:03:15Z   0 0 090000648605809f
FDA-2023-N-2177-0131 FDA None FDA-2023-N-2177 PRIA Reference 14 - Department of Health, Wadsworth Center, “Clinical Laboratory Evaluation Program RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:01:14Z   0 0 09000064860501a1
FDA-2023-N-2177-0130 FDA None FDA-2023-N-2177 PRIA Reference 10 - U.S. Government Publishing Office - Laboratory Testing in the Era of Precision Medicine RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:01:00Z   0 0 09000064860501a0
FDA-2023-N-2177-0127 FDA None FDA-2023-N-2177 PRIA Reference 8 - Cheng et al-The clinical and economic impact of inaccurate EGFR mutation tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-08T16:35:34Z   0 0 090000648604ef5c
FDA-2023-N-2177-0124 FDA None FDA-2023-N-2177 Request for Extension from Association for the Advancement of Blood and Biotherapies (AABB) Other Request for Extension 2023-10-05T04:00:00Z 2023 10 2023-10-05T04:00:00Z   2023-10-05T18:00:41Z   0 0 090000648603a4ed
FDA-2023-N-2177-0133 FDA None FDA-2023-N-2177 PRIA Reference 16 - Kalorama Information - The Worldwide Market for Laboratory-Developed Tests (LDTs) RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:01:40Z   0 0 0900006486052154
FDA-2023-N-2177-0134 FDA None FDA-2023-N-2177 PRIA Reference 20 - Performance Report to Congress - Medical Device User Fee Amendments FY 2022 RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-08T16:32:47Z   0 0 0900006486052155
FDA-2023-N-2177-0121 FDA None FDA-2023-N-2177 Memorandum from Elizabeth Hillebrenner to FDA CDRH Other Memorandum 2023-10-05T04:00:00Z 2023 10 2023-10-05T04:00:00Z   2023-10-05T17:06:33Z   0 0 090000648604ba44
FDA-2023-N-2177-0128 FDA None FDA-2023-N-2177 PRIA Reference 9 - American Association for Cancer Research - Re Request for Information Regarding 21st Cures RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:00:32Z   0 0 090000648604ee6e
FDA-2023-N-2177-0129 FDA None FDA-2023-N-2177 PRIA Reference 1 - CMS - Clinical Laboratory Improvement Amendments (CLIA) Post-Public Health Emergency (PHE) Guidance RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:00:49Z   0 0 090000648605019f
FDA-2023-N-2177-0132 FDA None FDA-2023-N-2177 PRIA Reference 15 - Congressional Budget Office - Federal Policies in Response to Declining Entrepreneurship RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-05T04:00:00Z 2023 10     2023-10-06T15:01:27Z   0 0 09000064860501a2
FDA-2023-N-2177-0046 FDA None FDA-2023-N-2177 Reference 3 - Congressional Research Service - FDA Regulation of LDTs RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:47:12Z   0 0 09000064860259b8
FDA-2023-N-2177-0083 FDA None FDA-2023-N-2177 Reference 40 - CMS - Laboratory Developed Tests LDTs Frequently Asked Questions RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T15:54:53Z   0 0 09000064860259e0
FDA-2023-N-2177-0090 FDA None FDA-2023-N-2177 Reference 47 - Warning Letter to Inova Genomics Laboratory re MediMap Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:04:51Z   0 0 09000064860259de
FDA-2023-N-2177-0091 FDA None FDA-2023-N-2177 Reference 48 - Framework for Regulatory Oversight of Laboratory Developed Tests LDTs Draft Guidance RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:05:09Z   0 0 09000064860259d2
FDA-2023-N-2177-0098 FDA None FDA-2023-N-2177 Reference 55 - Untitled Letter to Navigenics RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:09:03Z   0 0 0900006486025a00
FDA-2023-N-2177-0101 FDA None FDA-2023-N-2177 Reference 58 - HHS - FAQs on Laboratory Developed Tests LDT RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:10:22Z   0 0 09000064860259f3
FDA-2023-N-2177-0112 FDA None FDA-2023-N-2177 Reference 69 - It Has Come to Our Attention Letter to MD Biosciences re Zika Virus RNA by RT-PCR Assay RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:16:32Z   0 0 0900006486025a03
FDA-2023-N-2177-0006 FDA None FDA-2023-N-2177 PRIA Reference 19 - Reportlinker - Laboratory Developed Tests Market Size Share and Trends Analysis Report RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:34:05Z   0 0 090000648601d2a3
FDA-2023-N-2177-0068 FDA None FDA-2023-N-2177 Reference 25 - Rogus and Lurie - FDA Is Letting Harmful Lab-Developed Tests Fall Through the Cracks RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:56:38Z   0 0 09000064860259c9
FDA-2023-N-2177-0080 FDA None FDA-2023-N-2177 Reference 37 - Wang et al. - Challenges and Opportunities for Developing More Generalizable Polygenic Risk Scores RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:59:53Z   0 0 09000064860259ec
FDA-2023-N-2177-0057 FDA None FDA-2023-N-2177 Reference 14 - Vega et al. - Aligning Tumor Mutational Burden Quantification Across Diagnostic Platforms RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:53:23Z   0 0 09000064860259c7
FDA-2023-N-2177-0104 FDA None FDA-2023-N-2177 Reference 61 - Diamond and Lim - Memo Details HHS Push To Upend FDAs Testing Oversight RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:02:03Z   0 0 0900006486025a04
FDA-2023-N-2177-0020 FDA None FDA-2023-N-2177 PRIA Reference 36 - Hopewell et al. - No Impact of KIF6 Genotype on Vascular Risk and Statin Response RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:34:51Z   0 0 090000648601c64d
FDA-2023-N-2177-0022 FDA None FDA-2023-N-2177 PRIA Reference 38 - Conly et al. - Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:35:37Z   0 0 090000648601c65b
FDA-2023-N-2177-0032 FDA None FDA-2023-N-2177 PRIA Reference 49 - I. Eastern Research Group - Economic Analysis of Proposed Revisions to the Good Manufacturing Practices Regulation for Medical Devices Final Report RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:41:48Z   0 0 090000648601def5
FDA-2023-N-2177-0048 FDA None FDA-2023-N-2177 Reference 5 - Warning Letter to 23andMe re 23andMe Personal Genome Service RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:47:52Z   0 0 09000064860259aa
FDA-2023-N-2177-0051 FDA None FDA-2023-N-2177 Reference 8 - CDC - Strengthening Clinical Laboratories RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:48:53Z   0 0 09000064860259a7
FDA-2023-N-2177-0033 FDA None FDA-2023-N-2177 PRIA Reference 50 - I. Eastern Research Group - Economic Analysis of Proposed Revisions to the Good Manufacturing Practices Regulation for Medical Devices Addendum RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:42:10Z   0 0 090000648601def4
FDA-2023-N-2177-0019 FDA None FDA-2023-N-2177 PRIA Reference 35 - HHS - Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:34:23Z   0 0 090000648601d2a8
FDA-2023-N-2177-0028 FDA None FDA-2023-N-2177 PRIA Reference 46 - Requirements for Pregnancy and Lactation Labeling Final Regulatory Impact Analysis RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:40:19Z   0 0 090000648601def2
FDA-2023-N-2177-0035 FDA None FDA-2023-N-2177 PRIA Reference 52 - Microbiology Devices Reclassification of Nucleic Acid-Based Systems for Mycobacterium Tuberculosis Complex Final Regulatory Impact Analysis RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:42:52Z   0 0 090000648601df16
FDA-2023-N-2177-0027 FDA None FDA-2023-N-2177 PRIA Reference 44 - Agency Information Collection Activities - Reports of Corrections and Removals RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:39:55Z   0 0 090000648601def1
FDA-2023-N-2177-0002 FDA None FDA-2023-N-2177 PRIA Reference 13 - Memo to File - Information from the NYSDOH for the Preliminary Regulatory Impact Analysis for the LDTs Proposed Rule and Certain Related Analysis RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:20:48Z   0 0 090000648601d2a1
FDA-2023-N-2177-0041 FDA None FDA-2023-N-2177 PRIA Reference 64 - Gruber - Chapter 2 Public Finance and Public Policy RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:47:15Z   0 0 090000648601df1c
FDA-2023-N-2177-0050 FDA None FDA-2023-N-2177 Reference 7 - Lighthouse Lab Services - Industry Insights RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:51:40Z   0 0 09000064860259a8
FDA-2023-N-2177-0058 FDA None FDA-2023-N-2177 Reference 15 - Offit et al. - Regulation of Laboratory-Developed Tests in Preventive Oncology RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:53:46Z   0 0 09000064860259bc
FDA-2023-N-2177-0055 FDA None FDA-2023-N-2177 Reference 12 - Pfeifer et al. - Reference Samples To Compare Next-Generation Sequencing Test Performance RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:52:58Z   0 0 09000064860259cc
FDA-2023-N-2177-0079 FDA None FDA-2023-N-2177 Reference 36 - Martin et al. - Clinical Use of Current Polygenic Risk Scores May Exacerbate Health Disparities RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:59:41Z   0 0 09000064860259d3
FDA-2023-N-2177-0082 FDA None FDA-2023-N-2177 Reference 39 - Hoskins et al. - Association of Race-Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:00:26Z   0 0 09000064860259d4
FDA-2023-N-2177-0106 FDA None FDA-2023-N-2177 Reference 63 - Baumann - Virus Testing Push Leaves FDA Lab Oversight in a Bizarre Limbo RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:02:31Z   0 0 09000064860259f4
FDA-2023-N-2177-0077 FDA None FDA-2023-N-2177 Reference 34 - PRIA for LDTs RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T15:52:53Z   0 0 09000064860259d7
FDA-2023-N-2177-0075 FDA None FDA-2023-N-2177 Reference 32 - FDA Issues Warning Letter to Genomics Lab for Illegally Marketing Genetic Test RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T15:51:44Z   0 0 09000064860259da
FDA-2023-N-2177-0089 FDA None FDA-2023-N-2177 Reference 46 - Letter from Leslie Kux Assistant Commissioner for Policy FDA to Alan Mertz American Clinical Laboratory Association RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:04:31Z   0 0 09000064860259d5
FDA-2023-N-2177-0087 FDA None FDA-2023-N-2177 Reference 44 - Letter from D. Bruce Burlington M.D. Director FDA-CDRH to Jeffrey N. Gibbs Esq. Hyman Phelps McNamara P.C. RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:03:05Z   0 0 09000064860259dd
FDA-2023-N-2177-0099 FDA None FDA-2023-N-2177 Reference 56 - Laboratory Developed Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:09:27Z   0 0 09000064860259f2
FDA-2023-N-2177-0103 FDA None FDA-2023-N-2177 Reference 60 - HHS - Statement by HHS Secretary Xavier Becerra on Withdrawal of HHS Policy on Laboratory-Developed Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:12:20Z   0 0 09000064860259f8
FDA-2023-N-2177-0097 FDA None FDA-2023-N-2177 Reference 54 - Monkeypox mpox and Medical Devices RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:07:53Z   0 0 09000064860259f7
FDA-2023-N-2177-0114 FDA None FDA-2023-N-2177 Reference 71 - Direct-to-Consumer Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:17:12Z   0 0 0900006486025a07
FDA-2023-N-2177-0116 FDA None FDA-2023-N-2177 Reference 73 - Untitled Letter to Pathway Genomics Inc RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:23:10Z   0 0 0900006486025a0b
FDA-2023-N-2177-0007 FDA None FDA-2023-N-2177 PRIA Reference 21 - Haileamlak - Pandemics Will be More Frequent RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-08T15:23:38Z   0 0 090000648601c644
FDA-2023-N-2177-0120 FDA None FDA-2023-N-2177 Reference 77 - 510k Third Party Review Program RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:24:44Z   0 0 0900006486025a06
FDA-2023-N-2177-0118 FDA None FDA-2023-N-2177 Reference 75 - Transcript of the Molecular and Clinical Genetics Panel Meeting March 9 2011 RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:23:55Z   0 0 0900006486025a09
FDA-2023-N-2177-0111 FDA None FDA-2023-N-2177 Reference 68 - Government Accountability Office - COVID-19 - FDA Took Steps to Help Make Tests Available Policy for Future Public Health Emergencies Needed RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:16:05Z   0 0 09000064860259fe
FDA-2023-N-2177-0012 FDA None FDA-2023-N-2177 PRIA Reference 26 - National Cancer Institute - Cancer Stat Facts Common Cancer Sites RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:25:32Z   0 0 090000648601d2a6
FDA-2023-N-2177-0015 FDA None FDA-2023-N-2177 PRIA Reference 29 - Wao et al. - Survival of patients with non-small cell lung cancer without treatment RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:27:00Z   0 0 090000648601c648
FDA-2023-N-2177-0013 FDA None FDA-2023-N-2177 PRIA Reference 27 - National Cancer Institute - Age and Cancer Risk RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:25:54Z   0 0 090000648601d2a7
FDA-2023-N-2177-0043 FDA None FDA-2023-N-2177 PRIA Reference 67 - Hammitt and Liu - Effects of Disease Type and Latency on the Value of Mortality Risk RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:45:38Z   0 0 090000648601df1a
FDA-2023-N-2177-0072 FDA None FDA-2023-N-2177 Reference 29 - Ovarian Cancer Screening Tests - Safety Communication - FDA Recommends Against Use RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T15:45:14Z   0 0 09000064860259ba
FDA-2023-N-2177-0029 FDA None FDA-2023-N-2177 PRIA Reference 42 - Vyberg et al. - Immunohistochemical expression of HER2 in breast cancer - socioeconomic impact of inaccurate tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:40:47Z   0 0 090000648601c65c
FDA-2023-N-2177-0031 FDA None FDA-2023-N-2177 PRIA Reference 48 - Drlik - How Much Does it Cost to Develop a Medical Device RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:41:29Z   0 0 090000648601c65e
FDA-2023-N-2177-0102 FDA None FDA-2023-N-2177 Reference 59 - Memorandum to File - Withdrawal of August 2020 Policy Regarding Laboratory-Developed Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:11:12Z   0 0 09000064860259f0
FDA-2023-N-2177-0025 FDA None FDA-2023-N-2177 PRIA Reference 41 - McKnight and Hinton - Tort Costs in America - An Empirical Analysis of Costs and Compensation of the U.S. Tort System RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:41:21Z   0 0 090000648601deef
FDA-2023-N-2177-0052 FDA None FDA-2023-N-2177 Reference 9 - Ackerman et al. - The Promise and Peril of Precision Medicine RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:52:06Z   0 0 09000064860259b6
FDA-2023-N-2177-0061 FDA None FDA-2023-N-2177 Reference 18 - Shuren and Stenzel - Covid-19 Molecular Diagnostic Testing--Lessons Learned RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:54:44Z   0 0 09000064860259c8
FDA-2023-N-2177-0044 FDA None FDA-2023-N-2177 Reference 1 - Grand View Research - Laboratory Developed Tests Market Size Share and Trends Analysis Report RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:46:32Z   0 0 09000064860259a5
FDA-2023-N-2177-0084 FDA None FDA-2023-N-2177 Reference 41 - U.S. System of Oversight of Genetic Testing A Response to the Charge of the Secretary of Health and Human Services RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-09T22:14:40Z   0 0 09000064860259ed
FDA-2023-N-2177-0110 FDA None FDA-2023-N-2177 Reference 67 - Compliance Program Guidance Manual 7342.002 Inspection of Source Plasma Establishments Brokers Testing Laboratories and Contractors RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-09T23:44:48Z   0 0 09000064860259fc
FDA-2023-N-2177-0011 FDA None FDA-2023-N-2177 PRIA Reference 25 - Newman-Toker et al. - Rate of diagnostic errors and serious misdiagnosis-related harms RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-08T15:31:26Z   0 0 090000648601c646
FDA-2023-N-2177-0109 FDA None FDA-2023-N-2177 Reference 66 - Compliance Program Guidance Manual 7341.002 Inspection of Human Cells Tissues and Cellular and Tissue-Based Products (HCTPs) RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:15:23Z   0 0 09000064860259f1
FDA-2023-N-2177-0010 FDA None FDA-2023-N-2177 PRIA Reference 24 - Newman-Toker et al. - Burden of serious harms from diagnostic error in the USA RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:24:41Z   0 0 090000648601c645
FDA-2023-N-2177-0076 FDA None FDA-2023-N-2177 Reference 33 - Memorandum to File - Examples of IVDs Offered as LDTs that Raise Public Health Concerns RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T15:52:12Z   0 0 09000064860259d8
FDA-2023-N-2177-0018 FDA None FDA-2023-N-2177 PRIA Reference 34 - Robinson Eber and Hammit - Valuing COVID-19 morbidity risk reductions RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:34:03Z   0 0 090000648601c64c
FDA-2023-N-2177-0100 FDA None FDA-2023-N-2177 Reference 57 - HHS - Rescission of Guidances and Other Informal Issuances RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:09:48Z   0 0 09000064860259f5
FDA-2023-N-2177-0096 FDA None FDA-2023-N-2177 Reference 53 - It Has Come to Our Attention Letter to Texas Childrens Hospital and Houston Methodist Hospital re Zika Direct Test RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:07:13Z   0 0 09000064860259ff
FDA-2023-N-2177-0095 FDA None FDA-2023-N-2177 Reference 52 - Policy for Coronavirus Disease-2019 Tests Revised Guidance RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T16:06:52Z   0 0 09000064860259ee
FDA-2023-N-2177-0017 FDA None FDA-2023-N-2177 PRIA Reference 33 - Paltiel Zheng and Walensky - Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-08T15:41:38Z   0 0 090000648601c64b
FDA-2023-N-2177-0005 FDA None FDA-2023-N-2177 PRIA Reference 18 - AstuteAnalytica India Pvt. Ltd. - United States Clinical Laboratory Services Market RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:33:42Z   0 0 090000648601d2a0
FDA-2023-N-2177-0023 FDA None FDA-2023-N-2177 PRIA Reference 39 - Blue Cross and Blue Shield of Minnesota Files Lawsuit Against GS Labs RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:38:06Z   0 0 090000648601deed
FDA-2023-N-2177-0053 FDA None FDA-2023-N-2177 Reference 10 - Begley - Genetic Testing Fumbles Revealing Dark Side of Precision Medicine RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:52:22Z   0 0 09000064860259a9
FDA-2023-N-2177-0063 FDA None FDA-2023-N-2177 Reference 20 - Clark - For a Host of Vital Lab Tests No FDA Oversight Exists RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:55:08Z   0 0 09000064860259bb
FDA-2023-N-2177-0065 FDA None FDA-2023-N-2177 Reference 22 - Kliff and Bhatia - When They Warn of Rare Disorders These Prenatal Tests Are Usually Wrong RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:55:42Z   0 0 09000064860259be
FDA-2023-N-2177-0066 FDA None FDA-2023-N-2177 Reference 23 - Robinson Carter and Brindley - The Changing Regulatory Landscape for Laboratory Developed Tests RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:55:59Z   0 0 09000064860259c3
FDA-2023-N-2177-0045 FDA None FDA-2023-N-2177 Reference 2 - Pew Charitable Trusts - The Role of Lab-Developed Tests in the In Vitro Diagnostics Market RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T13:51:05Z   0 0 09000064860259b7
FDA-2023-N-2177-0030 FDA None FDA-2023-N-2177 PRIA Reference 47 - Batavia and Goldenberg - Strategic Planning and Costs of FDA Regulation RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-08T17:14:40Z   0 0 090000648601c65d
FDA-2023-N-2177-0094 FDA None FDA-2023-N-2177 Reference 51 - Policy for Monkeypox Tests To Address the Public Health Emergency Guidance RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-09T22:29:53Z   0 0 09000064860259fa
FDA-2023-N-2177-0085 FDA None FDA-2023-N-2177 Reference 42 - American Cancer Society Cancer Action Network - Administration Declines to Issue FDA Guidance on LDT Oversight RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:00:52Z   0 0 09000064860259cf
FDA-2023-N-2177-0086 FDA None FDA-2023-N-2177 Reference 43 - Advanced Medical Technology Association - AdvaMed Statement on HHS Reversal of LDT Rescission Notice RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:01:03Z   0 0 09000064860259df
FDA-2023-N-2177-0108 FDA None FDA-2023-N-2177 Reference 65 - Fortune 500 - The Largest Companies in the U.S. by Revenue RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-10T14:03:08Z   0 0 09000064860259ef

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 538.283ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API